Your browser doesn't support javascript.
loading
Microenvironment Is a Key Determinant of Immune Checkpoint Inhibitor Response.
Cho, Shih-Feng; Anderson, Kenneth C; Tai, Yu-Tzu.
Afiliação
  • Cho SF; Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Anderson KC; Division of Hematology and Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Tai YT; Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
Clin Cancer Res ; 28(8): 1479-1481, 2022 04 14.
Article em En | MEDLINE | ID: mdl-35121621
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Supressoras Mieloides / Inibidores de Checkpoint Imunológico Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Supressoras Mieloides / Inibidores de Checkpoint Imunológico Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article